The effect of intravenous ferric carboxymaltose on the arrhythmic burden of HFrEF patients with cardiac implantable electronic devices: RESAFE-HF study preliminary results
Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)
0
follower
38
more
presentations
in this session
Empagliflozin improves cardiovascular and renal outcomes in patients with preserved ejection fraction irrespective of age: insights from the EMPEROR-Preserved trial
Combination treatment by epoxyeicosatrienoic acid analog and angiotensin-convertase enzyme inhibitor in congestive heart failure: a preclinical study on animal model
Long-term prognostic implications of in-hospital changes in N-terminal pro-B-type natriuretic peptide levels among hospitalized patients with atrial fibrillation with or without heart failure